2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV

Liver International

Volumn 36, Issue 10, 2016, Pages 1442-1449

  Bottero, Julie ^a,b,m   Brouard, Cécile ^c,m   Roudot Thoraval, Francoise ^m   Deuffic Burban, Sylvie ^e,f,g,h,m   Hofliger, Philippe ^i,m   Abergel, Armand ^j,m   Volant, Johann ^k,m   Dhumeaux, Daniel ^d   Yazdanpanah, Yazdan ^e,f,l,m   Aubert, Jean Pierre ^m   Bourdillon, François ^m   Boyer, Nathalie ^m   Chevaliez, Stéphane ^m   Foucher, Juliette ^m   Gautier, Arnaud ^m   Le Gall, Jean Marie ^m   Ouzan, Denis ^m   Partouche, Henri ^m   Semaille, Caroline ^m   Spenatto, Nathalie ^m  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITÉ DE LILLE   (France)

^h UNIV LILLE   (France)

ⁱ UNIVERSITÉ CÔTE D'AZUR   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k Federation SOS hepatites   (France)

^l BICHAT HOSPITAL   (France)

^m NONE

more..

Author keywords

hepatitis B; hepatitis C; screening; testing

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; CHRONIC HEPATITIS C; DEVELOPED COUNTRY; FEMALE; FIRST TRIMESTER PREGNANCY; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRACTICE GUIDELINE; PREGNANT WOMAN; SEROPREVALENCE; VIRUS TRANSMISSION;

EID: 84986290313     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.13135     Document Type: Article

References (46)

1. Pawlotsky JM. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 2014; 146: 1176–92.
2. European Association for Study of Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167–85.
3. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584–93.
4. Grebely J, Bilodeau M, Feld JJ, et al. The Second Canadian Symposium on hepatitis C virus: a call to action. Can J Gastroenterol 2013; 27: 627–32.
5. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep 2012; 61: 1–32.
6. Deuffic-Burban S, Deltenre P, Buti M, et al. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 2012; 143: 974–85 e914.
7. Hatzakis A, Wait S, Bruix J, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat 2011; 18(Suppl. 1): 1–16.
8. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57: 1–20.
9. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010; 82: 546–55.
10. Dhumeaux D. [Management of people infected by HBV or HCV. Recommendations report.] 2014 Available at www.sante.gouv.fr/pdf/Rapport_Prise_en_charge_Hepatites_2014.pdf. Accessed: 7 September 2015.
11. Smith BD, Morgan RL, Beckett GA, et al. Hepatitis C virus testing of persons born during 1945–1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med 2012; 157: 817–22.
12. Agence nationale d'accréditation et d’évaluation en santé (ANAES). [Hepatitis C screening - populations to be screened and screening procedures. Recommendations of the Experts Committee set up by the ANAES] 2001 Available at http://www.has-sante.fr/portail/upload/docs/application/pdf/hepatite.pdf. Accessed: 7 September 2015.
13. Haute Autorité de Santé (HAS). Stratégies de dépistage biologique des hépatites virales B et C. 2011 Available at http://www.has-sante.fr/portail/jcms/c_1050355/fr/strategies-de-depistage-biologique-des-hepatites-virales-b-et-c. Accessed: 7 September 2015.
14. Ministère de la Santé et des Sports. [2015 vaccinations calendar and vaccinations recommendations.] 2015 Available at http://www.sante.gouv.fr/IMG/pdf/Calendrier_vaccinal_2015.pdf. Accessed: 7 September 2015.
15. Brouard C, Le Strat Y, Larsen C, et al. The undiagnosed chronically-infected HCV population in france. Implications for expanded testing recommendations in 2014. PLoS ONE 2015; 10: e0126920.
16. Brouard C, Delarocque-Astagneau E, Meffre C, et al. Trends of hepatitis C screening in France through Rena-VHC and hepatology reference centres surveillance systems, 2000–2007. Bull Epidemiol Hebd 2009; 20/21: 199–204.
17. Brouard C, Pioche C, Le Vu S, et al. [HBs antigen screening: to be improved]. 69èmes Journées scientifiques de l'Association Française pour l'Etude du Foie (AFEF). Paris. 2011.
18. Brouard C, Leon L, Pioche C, et al. [Hepatitis B and C screening in France in 2010. The LaboHep 2010 Study]. Bull Epidemiol Hebd 2013; 19: 205–9.
19. Pioche C, Leon L, Larsen C, et al. [Hepatitis B and C screening in France in 2013. The LaboHep 2013 Study]. Bull Epidemiol Hebd 2015; 27: 478–84.
20. Delarocque-Astagneau E, Meffre C, Dubois F, et al. The impact of the prevention programme of hepatitis C over more than a decade: the French experience. J Viral Hepat 2010; 17: 435–43.
21. Jauffret-Roustide M, Le Strat Y, Couturier E, et al. A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infect Dis 2009; 9: 113.
22. Brouard C, Larsen C, Pioche C, et al. [Epidemiology of hepatitis B and hepatitis C - focus on screening] 86ème rencontre du Crips Île-de-France 2013.
23. Brouard C, Gautier A, Saboni L, et al. Hepatitis B knowledge, perceptions and practices in the French general population: the room for improvement. BMC Public Health 2013; 13: 576.
24. Vignier N, Jestin C, Arwidson P. Perceptions de l'hépatite B et de sa prévention. Premiers résultats d'une étude qualitative. Bull Epidemiol Hebd 2009; 20–21: 212.
25. Tosini S, Rioux C, Pelissier G, Bouvet E. Étude de perception des risques de l'hépatite virale B et de sa prévention vaccinale dans une Consultation de dépistage anonyme et gratuit (CDAG) parisienne en 2007. Bull Epidemiol Hebd 2009; 20–21: 217–20.
26. Bottero J, Boyd A, Lemoine M, et al. Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region. PLoS ONE 2014; 9: e92266.
27. Gautier A, Jestin C. [General practitionners practices for viral hepatitis screening in France in 2009]. BEHWeb 2011; 1: www.invs.sante.fr/behweb/2011/01/r-2.htm. Accessed: 7 September 2015.
28. Kowalik C. Evaluation of the Hepatitis C Screening in Général Medicine Practice in the Annecy Area in 2009. Grenoble, France: Joseph Fourié University, 2009.
29. Livrozet JM, Py AM, Elghosi B, et al. Hepatitis C screening in general practice. Rev Prat Médecine Générale 2005; 19: 895–9.
30. Haute Autorité de Santé (HAS). HIV infection screening in France - laboratory tests and algorithms. 2008 Available at http://www.has-sante.fr/portail/jcms/c_866949/en/hiv-infection-screening-in-france-screening-strategies?xtmc=%26xtcr=2. Accessed: 7 September 2015.
31. Cazein F, Le Strat Y, Dutil J, Couturier S, Ramus C, Semaille C. HIV infection screening in France, 2003–2012. Bull Epidemiol Hebd 2013; 33–34: 410–6.
32. Morlat P. [Management of people leaving with HIV. 2013 report: experts recommendations]. La documentation française 2013.
33. British HIV Association (BHIVA). UK National Guidelines for HIV Testing, 2008.
34. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pai NP. Rapid point-of-care first-line screening tests for hepatitis B infection: a meta-analysis of diagnostic accuracy (1980–2010). Am J Gastroenterol 2012; 107: 1306–13.
35. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N. Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis. Ann Intern Med 2012; 157: 558–66.
36. Bottero J, Boyd A, Gozlan J, et al. Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. J Hepatol 2013; 58: 473–8.
37. Chevaliez S, Poiteau L, Rosa I, et al. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clin Microbiol Infect 2016; 22: 459.e1–6.
38. Haute Autorité de Santé (HAS). [Use of rapid point-of-care first-line screening tests in hepatitis C screening strategy]. In. Saint Denis, France; 2014.
39. Morano JP, Zelenev A, Lombard A, et al. Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic. J Community Health 2014; 39: 922–34.
40. Stockman LJ, Guilfoye SM, Benoit AL, Vergeront JM, Davis JP. Rapid hepatitis C testing among persons at increased risk for infection–Wisconsin, 2012–2013. MMWR Morb Mortal Wkly Rep 2014; 63: 309–11.
41. Bottero J, Boyd A, Gozlan J, et al. Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage. Open Forum Infect Dis 2015; 2: ofv162.
42. Brouard C, Le Strat Y, Pillonel J, Larsen C, Semaille C. Characteristics of undiagnosed HBV or HCV chronically infected population in France: a need for reconsidering testing strategies (abstract O88). J Hepatol 2014; 60: S36.
43. Supervie V, Ndawinz JD, Lodi S, Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS 2014; 28: 1797–804.
44. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014; 59: 765–73.
45. Cousien A, Tran VC, Deuffic-Burban S, et al. Hepatitis c treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs. Hepatology 2016; 63: 1090–101.
46. Bottero J, Boyd A, Gozlan J, et al. Effectiveness of Hepatitis B rapid tests towards linkage to care: results of a randomized, multicenter study. Eur J Gastro Hepatol 2016; 28: 633–9.